Fresenius SE & Co. KGaA MTN v.2019(2028/2029)

BID
-
ASK
-
Sell Buy0 Nom.0 Nom.
06/12, 22:00:04 PM

SPREAD (ACT/ REL)- / -
CHANGE COMPARED WITH PREVIOUS DAY (PRICE)0.15%
TODAY'S HIGH (PRICE)99.977
TODAY'S LOW (PRICE)99.613
Week 52 High (Price)101.78
Week 52 Low (Price)98.55

Yield Curves

Type of financial instrument

Corporate Bond

Sub-Type

Health Care

Yield

2.94

Yield spread Bundesanleihe

0.3538

Tradable for private investors

Yes

Minimum amount tradeable unit

1,000.00

Maturity

15/02/2029

Interest Rate

2.875 %

Currency

Euro

Facts & figures

Price data


TRADE PLATFORM	Börse Stuttgart (XSTU)
LAST PRICE / YIELD	99.824 G / 2.94	0 Units
PRICE DETERMINATION TIME	06/12/2026 / 09:48:08 PM
DAILY VOLUME (NOMINAL)	0
YIELD SPREAD	0.3538
FIXINGPRICE	-
DAILY HIGH / LOW	99.977	99.613
PREV. DAY'S PRICE	99.679	(06/11)
CHANGE DAY BEFORE	+0.14	0.15 %
52 WEEK HIGH / LOW	101.783 (07/22)	98.546 (03/23)

More Price Information

Master Data


WKN	A2NBMT
ISIN	XS1936208419
SYMBOL	-
EXCHANGE SEGMENT	Freiverkehr
TYPE OF FINANCIAL INSTRUMENT	Corporate Bond
SUB-TYPE	Health Care
ISSUER	Fresenius SE & Co. KGaA
S&P RATING	Please log in to view this field
(TRADING) SEGMENT / TICKS	-/ -
TRADING HOURS	07:30:00 AM - 10:00:00 PM
INTEREST RATE	2.875 %
INTEREST RUN FROM	21/01/2019
NEXT INTEREST PAYMENT	15/02/2027
UNIT INTEREST FROM NOMINAL AMMOUNT	0.953 %


TRADING CURRENCY / NOTATION	Euro/ Percent
NOMINAL CURRENCY	Euro
SETTLEMENT CURRENCY	Euro
QUOTATION	Continuous trading
ISSUING VOLUME	500.00 Mil.
MINIMUM AMOUNT TRADEABLE UNIT	1,000.00
SMALLEST TRADEABLE UNIT	1,000.00
MATURITY	15/02/2029
MARKET MAKER	-
STEP UP/ DOWN WHEN RATING CHANGES	No
STEP UP FIXED AT ISSUE	No
STEP DOWN FIXED AT ISSUE	No
BOND CALLABLE BY THE ISSUER	Yes
BOND IS SUBORDINATED	No

Description

Callable bond.

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create an account here.

Company profile

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.